The role of β-2-microglobulin and cystatin C as urinary biomarkers of focal segmental glomerulosclerosis in the setting of paediatric HIV infection
Article Sidebar
Main Article Content
Abstract
Background. Africa has the highest rate of HIV infection, and HIV-associated nephropathy (HIVAN) is one of the most frequent kidney
diseases observed in children. HIVAN in children usually presents as a form of nephrotic syndrome, predominantly focal segmental
glomerulosclerosis (FSGS) on histopathology, that often leads to chronic kidney failure.
Objective. This study determined the urinary concentrations of β-2-microglobulin (β2M) and cystatin C proteins in children with HIVAN
and primary FSGS.
Methods. The study group comprised 34 children; 14 with HIVAN and 20 with primary FSGS. The control groups were 20 HIV-positive
and 20 HIV-negative children with no kidney disease. Urine samples collected from these 74 children were stored at -80°C. Bio-Plex
technology was used to analyse the urinary protein concentration of cystatin C and β2M.
Results. A significant increase in urinary β2M levels was observed in the HIVAN group compared with the HIV-negative group
(p=0.0240). No other statistically significant differences in urinary β2M concentrations were noted across the study groups. Urinary
cystatin C levels were significantly increased in primary FSGS children compared with both HIV-negative (p=0.0041) and HIV-positive
controls (p=0.0256). Urinary cystatin C displayed a significant increase in the primary FSGS compared with the HIVAN group (p=0.0150).
No significant differences in urinary cystatin C levels were noted in the HIVAN group compared with the HIV-negative and HIV-positive
control groups.
Conclusion. Urinary cystatin C has promising prognostic value to predict primary FSGS from HIVAN.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
UNAIDS Data 2020. 2021. https://www.unaids.org/en/resources/fact-sheet (accessed 25 October 2021).
Global Statistics. The Global HIV/AIDS Epidemic. Last updated 25 June 2021.
https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics
(accessed 31 October 2021).
Jindal AK, Tiewsoh K, Pilania RK. A review of renal disease in children with HIV
infection. Infect Dis 2017;1-12. https://doi.org/10.1080/23744235.2017.1371852
HIVAN, Pediatric. In: Trachtman H, Herlitz L, Lerma E, Hogan J, editors. Glomerulonephritis. Cham: Springer, 2019. https://doi.org/10.1007/978-3-
-49379
Ramsuran D, Bhimma R, Ramdial PK, et al. The spectrum of HIV-related nephropathy in children. Pediatric Nephrol 2012;27(5):21-27. https://doi. org/10.1007/s00467-011-2074-8
Soler-Palacín P, Melendo S, Noguera-Julian A, et al. Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens. AIDS 2011;25(2):171-176. https://doi.org/10.1097/ QAD.0b013e328340fdca
Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exper Biol Med 2004;229(1):85-98. https://doi. org/10.1177/153537020422900111
Kiffel J, Rahimzada Y, Trachtman H. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis 2011;18(5):332-382. https://doi.org/10.1053/j.ackd.2011.03.005
Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: Perspectives on translation. Clin J Am Soc Nephrol 2008;3(2):481-490. https://doi. org/10.2215/CJN.03520807
Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: Behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 2014;85(1):49-61. https://doi.org/10.1038/ki.2013.444
Giorgi A. Renal Biopsy. 2016. http://www.healthline.com/health/renal- biopsy#ReadThisNext8 (accessed 25 July 2017).
Bethea M, Forman D. Beta 2-microglobulin: Its significance and clinical usefulness. Ann Clin Lab Sci 1990;20(3):163-168.
Dajak M, Ignjatović S, Stojimirović B, Gajić S, Majkić-Singh N. Beta-trace protein as a marker of renal dysfunction in patients with chronic kidney disease: Comparison with other renal markers. J Med Biochem 2010;29(2):66-72.
Wu I, Parikh CR. Screening for kidney diseases: Older measures versus novel biomarkers. Clin J Am Soc Nephrol 2008;3(6):1895-1901. https://doi. org/10.2215/CJN.02030408
Deyà-Martínez À, Fortuny C, Soler-Palacín P, et al. Cystatin C: A marker for inflammation and renal function among HIV-infected children and adolescents. Pediatr Infect Dis J 2016;35(2):196-200. https://doi.org/10.1097/ INF.0000000000000960
Senguttuvan P. Human immunodeficiency virus-associated nephropathy (HIVAN) in Indian children. Open Urology Nephrol J 2014;7(1).
Inc BRL. Bio-Plex Pro RBM Kidney Toxicity Assays, Instruction Manual. www.bio-rad.com/webroot/web/pdf/lsr/literature/10028258.pdf (accessed 27 February 2017).
D’Agati V, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004;43(2):368-382. https://doi.org/10.1053/j.ajkd.2003.10.024
Nishijima T, Shimbo T, Komatsu H, et al. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: A diagnostic accuracy study. J Infect Chemother 2013;19(5):850-857. https://doi.org/10.1007/s10156- 013-0576-y
Soler-GarcíaÁA,JohnsonD,HathoutY,RayPE.Iron-relatedproteins:Candidate urine biomarkers in childhood HIV-associated renal diseases. Clin J Am Soc Nephrol 2009;4(4):763-771. https://doi.org/10.2215/CJN.0200608
Sonkar G, Singh R. A preliminary study on the significant value of beta-2- microglobulin over serum creatinine in renal transplant rejection and renal failure. Singapore Med J 2008;49(10):786.
Erkan E, Garcia CD, Patterson LT, et al. Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: Roles of proteinuria and Fas-dependent pathways. J Am Soc Nephrol 2005;16(2):398-407. https://doi.org/10.1681/ ASN.2003100861.
Kim DW, Lim IS. Analysis of urine β2-microglobulin in pediatric renal disease. Korean J Pediatr 2007;50(4):369-375.
Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: Diagnostic accuracy of urinary beta-trace protein. Am J Physiology-Renal Physiol 2010. https://doi.org/10.1152/ajprenal.00507.2009
Tony E, Mohammed H, Fathi N, Tony A, Afifi O. Serum and urinary biomarkers endothelin-1, beta-2 microglobulin, cystatin C, galectin-3 and alpha-1-acid glycoprotein; can they surrogate clinical and histological staging in lupus nephritis patients? J Arthritis 2016;5(223):2.
Soler-García ÁA, Rakhmanina NY, Mattison PC, Ray PE. A urinary biomarker profile for children with HIV-associated renal diseases. Kidney Int 2009;76(2):207-214. https://doi.org/10.1038/ki.2009.115
Perazzo S, Soler‐García ÁA, Hathout Y, Das JR, Ray PE. Urinary biomarkers of kidney diseases in HIV‐infected children. PROTEOMICS-clinical applications. 2015;9(5-6):490-500. https://doi.org/10.1002/prca.201400193
Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A. Short communication. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration. Antiviral Therapy 2006;11:641-645.
Luthra K. Antiviral activity of cystatin C against HIV. Indian J Med Res 2015;141(4):383. https://doi.org/10.4103/0971-5916.159242
Vernekar V, Velhal S, Bandivdekar A. Evaluation of cystatin C activities against HIV. Indian J Med Res 2015;141(4):423. https://doi.org/10.4103/0971- 5916.159282